![Novel Pathogen Reduction Technologies Effectively Treat Whole Blood Products](https://www.g2intelligence.com/wp-content/uploads/2022/06/June24-2022.News_.Miriam.PRTs-iStock-1800x1250-1-1080x675.jpg)
Novel Pathogen Reduction Technologies Effectively Treat Whole Blood Products
Researchers are actively developing PRTs for use in whole blood products to target bacteria and viruses, including SARS-CoV-2.
Researchers are actively developing PRTs for use in whole blood products to target bacteria and viruses, including SARS-CoV-2.
In clinical training sets, the new test allowed SARS-CoV-2 antibodies to be detected using widely available glucometers.
The UK-based diagnostics firm received CE marks for a diabetes test, CHF test, as well as an analyzer, and two COVID-19 tests.
Combined with rising labor costs, COVID-19, and other challenges, stakeholders say the cuts will negatively impact patient care.
Experts offer advice in a recent commentary article on treating patients who may have monkeypox during the current COVID-19 pandemic.